Call Options Transactions Made in Q4 2023 in Travere Therapeutics, Inc. (TVTX)
This table provides information about the institutional ownership of Travere Therapeutics, Inc. (TVTX) during Q4 2023. The information is specifically focused on institutions that hold call options of Travere Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
BUY
|
CALL |
109KNew |
$595K - $1.04M
|
109K
$2.15M
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
BUY
|
CALL |
52.2K+ 44.92% |
$284K - $496K
|
168K
$3.31M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-50.6K- 40.22% |
$275K - $481K
|
75.2K
$1.48M
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-73.5K- 58.47% |
$400K - $698K
|
52.2K
$1.03M
|
|
|
Feb 14, 2024
Q4 2023
|
Gts Securities LLC
New York, NY |
SELL
|
CALL |
-82.3K- 87.83% |
$448K - $782K
|
11.4K
$224K
|
|
|
Feb 14, 2024
Q4 2023
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
CALL |
-385K- 92.33% |
$2.09M - $3.66M
|
32K
$630K
|